Clinical Trials Directory

Trials / Unknown

UnknownNCT02517957

Xia Shi Surgical Treatment for Eczema Multi-center Clinical Research

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
342 (estimated)
Sponsor
Shanghai Yueyang Integrated Medicine Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

On the basis of Xiashi skin surgery clinical experience, this project adopts the multicenter, randomized, double-blind, controlled trial of design type. Objective, normative evaluation of traditional Chinese medicine cool blood latent town effectiveness of therapeutic regimen in the treatment of eczema, security, and control of the relapse of situation, provide high-level evidence-based basis for traditional Chinese medicine treatment of eczema, aims to form suitable for popularization and application of traditional Chinese medicine in the treatment of eczema.

Conditions

Interventions

TypeNameDescription
DRUGFuroic acid loperamide hydrochloride creamApply to lesion area without erosion, drainage, 1 times a day, continuous use 1 week after according to disease reduction or withdrawal, the longest do not exceed 4 weeks. Pure dry area or no skin itching area should not be applied.
DRUGMullite ointmentApplies to a blister, pustule, erosion, ulcer, leaking or comorbid folliculitis, in skin lesions of 2 times a day, 5 days for one period of treatment, but for two consecutive period of treatment
DRUG3% boric acid solution3% boric acid solution is suitable for the erosion seepage skin, can open intermittent shi fu, 5-10 min each time, 2 times daily or several times.
DRUGZine oxideIn wet apply the break to zinc oxide preparation for external use only, when erosion seepage control is disabled in skin lesions.

Timeline

Start date
2015-08-01
Primary completion
2017-08-01
First posted
2015-08-07
Last updated
2015-08-07

Source: ClinicalTrials.gov record NCT02517957. Inclusion in this directory is not an endorsement.